Release date: February 2017
Valid through: February 2020
This activity is intended for the infectious disease specialist.
- Zika Virus and Risk of Congenital Abnormalities
- Intrauterine Zika Virus Infection — Not Just Microcephaly at Birth
- A Short Course of Antibiotics for Acute Otitis Media in Children Leads to Worse Outcomes Compared to Standard Course Therapy
- Decreasing Malaria Mortality in Africa
- Ventilator Associated Pneumonia with Minimal Ventilatory Requirements – Discontinuing Antibiotics after Three Days
- Flu in Pregnancy: Increased Inflammation Demonstrated
- Bezlotoxumab Injection (Zinplava)
- Discharge Antibiotic Prescriptions Are Often Inappropriate with Regard to Choice, Dose, Duration
- Discuss the diagnosis of infectious diseases
- Explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
- Discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
- Discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies
- Maximum of 3.0 AMA PRA Category 1 Credits™
This activity is sponsored by AHC Media.
AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Stan Deresinski, MD, FACP, FIDSA, Clinical Professor of Medicine, Stanford University
Philip R. Fischer, MD, DTM&H, Professor of Pediatrics, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN
Dean Winslow, MD, Professor of Medicine, Division of General Medical Disciplines, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine
Richard R. Watkins, MD, MS, FACP, Division of Infectious Diseases, Akron General Medical Center, Akron, OH; Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH
Hal B. Jenson, MD, FAAP, Professor of Pediatric and Adolescent Medicine, Dean, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI
William Elliott, MD, FACP, Medical Director, Pharmacy, Northern California Kaiser Permanente, Assistant Professor of Medicine, University of California, San Francisco
James Chan, PharmD, PhD, Pharmacy Quality and Outcomes Manager, Kaiser Permanente, Oakland, CA.
Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine,
AHC Media Executive Editor: Shelly Morrow Mark
Infectious Disease Alert’s editor, Stan Deresinski, MD, FACP, FIDSA, peer reviewer Patrick Joseph, MD, Updates author, Carol A. Kemper, MD, FACP, peer reviewer Kiran Gajurel, MD, senior accreditations officer Lee Landenberger, executive editor Shelly Morrow Mark, and assistant editor Jonathan Springston report no financial relationships to this field of study.
Dr. Richard Watkins reports that he has received research support from Allergan. Dr. Philip Fischer, Dr. Hal Jenson, Dr. Dean Winslow, William Elliott, MD, and James Chan, PharmD, report no financial relationships relevant to this field of study.
Copyright 2017, AHC Media. All rights reserved.